Abstract 99. Jahrestagung der DOG, 29. 9. - 2. 10. 01 im ICC, Berlin

Anmeldung zur Tagung
   Registration
Grußwort
   Invitation
Themen
   Topics
Allgemeiner Ablauf
   General overview
Wissenschaftliches Programm
   Scientific program
Kurse
   Courses
Symposien
   Symposiums
Frühstück mit Spezialisten
   Breakfast with specialists
Arzthelferinnen-Fortbildung
Rahmenprogramm
   Social program
DOG Information
   DOG Information
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Ausstellerliste
   Exhibitors
Sponsoren
   Sponsors
Teilnahmegebühren
   Registration fees
Impressum



Diode Laser Photocoagulation in Retinopathy of Prematurity Stages 3+ and 4+ over a 10-year period

Seiberth V., Woldt C.

Klinik für Augenheilkunde, Marienhospital Osnabrück, D-49074 Osnabrück

Background: In the late decade laser photocoagulation has surpassed the former goldstandard cryocoagulation in retinopathy of prematurity (ROP) treatment. We report our 10-year experience with diode laser photocoagulation in acute ROP stages 3+ and 4+ (International Classifiction 1984).
Methods: To evaluate the efficacy and safety of diode laser photocoagulation we included 172 eyes with stage 3+ and stage 4+ ROP of 88 very low birth weight infants (gestational age 24 to 31 weeks, mean ± SD 26.4 ± 1.7 weeks; birth weight 430 to 1400 g, 842 ± 207 g) in a prospective clinical study between 1992 and 2001. Photocoagulation treatment was performed transpupillarly (142 eye) or transsclerally (30 eyes) using a diode laser (wavelength 810 nm). Seven eyes (4.1 %) had additional retinal detachment surgery using an encircling band. Follow-up ranged from 2 to 74 months.
Results: In 158 (91.9 %) of the 172 eyes the retina was attached without dragging or with mild dragging after laser coagulation and additional retinal detachment surgery. Of 164 eyes treated in stage 3+ 152 (92.7 %) ended with attached retina , 6 eyes in stage 4 and 6 eyes in stage 5 ROP. Of the 8 eyes treated in stage 4+ 6 eyes ended with attached retina, 2 eyes in stage 4 and none in stage 5 ROP. No adverse side effects as a result of diode laser treatment were noticed except for a small amount of retinal/preretinal bleeding in the ridge in 48 eyes (27.9 %) and a small postoperative anterior chamber bleeding in two eyes (1.2 %) with tunica vasculosa lentis. There were neither lenticular opacities nor was there cataract formation or any severe anterior segment complication.
Conclusion: Diode laser photocoagulation is an effective treatment for stage 3+ ROP. In stage 4+ ROP diode laser treatment is less effective. There were no severe side effects due to coagulation treatment.




DOG HomepageZurück / Back